Since approximately 100 million in the US suffer from chronic pain, NeuroMetrix has come out with Quell, a wearable device that can be worn 24 hours a day to help better manage chronic pain, neurological diseases and sleep disorders. It uses non-invasive neurostimulation technology to provide relief from pain, particularly neuropathic pain due to diabetes, fibromyalgia and sciatica.
NeuroMetrix of Waltham will be jumping into the market for wearable electronic devices, which is projected to hit nearly $13 billion in worldwide sales in 2018.
But the company’s new Quell device — an over-the-counter version of its Sensus device for management of chronic pain — is different from most of those devices in one significant way. While most monitor the body, as with the FitBit wristband and the Apple Watch, Quell is an actual medical device that is used to manage pain.
In the attached video, I spoke to NECN’s Ally Donnelly about the first unveiling of NeuroMetrix’ (Nasdaq: NURO) product over this past weekend at the Consumer Electronics Show in Las Vegas.
Price :: $200-$250 Could be!